Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
What US FDA’s Pazdur’s Long Oncology Track Record Portends For CDER
Nov 13 2025
•
By
Sarah Karlin-Smith
26-year US FDA vet Richard Pazdur was promoted to CDER director Nov. 11.
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from US FDA
More from Agency Leadership